94 Maeda, K
The FDA has approved certain medications (Victoza, Ozempic, Trulicity) for cardiovascular risk reduction in patients with established cardiovascular disease and type 2 diabetes, and Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who have overweight or obesity
This includes discussing your medical history, assessing your eligibility for medications like Wegovy and Zepbound based on FDA guidelines, and ordering any necessary lab work
Having built Noom to be the ultimate GLP-1 companion, we believe the company is well positioned in the emerging PDURS landscape. Noom repeatedly found that people interested in starting a medicated weight loss journey expect to engage in multimodal weight loss
Roche Johnson & Johnson Zealand Pharma Hanmi Pharmaceutical Rhythm Pharmaceuticals Structure Therapeutics Viking Therapeutics Altimmune Roche Diabetes Care Biocon Genfit Regeneron Pharmaceuticals Novo Nordisk Headquarters: Bagsvrd, Denmark Novo Nordisk is a global pharmaceutical company, kind of a leading player in diabetes and obesity care